CIBC World Market
AGIO icon

CIBC World Market’s Agios Pharmaceuticals AGIO Stock Holding History

CIBC World Market’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,831
Closed -$469K – 1275
2020
Q4 		$469K Buy
10,831
+48
+0.4% +$1.9K ﹤0.01% 968
2020
Q3 		$377K Sell
10,783
-20,156
-65% -$883K ﹤0.01% 900
2020
Q2 		$1.66M Buy
+30,939
New +$1.43M 0.01% 520

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Market's AGIO Position: Q1 2021 in Review

CIBC World Market sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 10,831 shares — an estimated $469K sold.

CIBC World Market first reported a position in AGIO in Q2 2020 and held it in 3 quarters. The position peaked at $1.66M in Q2 2020. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • CIBC World Market reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • CIBC World Market sold 10,831 Agios Pharmaceuticals shares in Q1 2021, an estimated $469K.
  • CIBC World Market first reported a position in Agios Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • CIBC World Market's Agios Pharmaceuticals position peaked at $1.66M in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on CIBC World Market's 13F filing for Q1 2021, filed 11 May 2021.